Open AccessPosterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient
Author(s) -
Bora Korkmazer,
Murat Ozogul,
Emil Hikmat,
Hüseyin Kılıç,
Fatih Aygün,
Serdar Arslan,
Osman Kızılkılıç,
Naci Koçer
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003130
Subject(s) - posterior reversible encephalopathy syndrome , medicine , encephalopathy , coronavirus , pneumonia , covid-19 , disease , central nervous system , infectious disease (medical specialty) , viral pneumonia , immunology , pediatrics , pathology , magnetic resonance imaging , radiology , outbreak
Novel coronavirus disease 2019 is a viral infectious disease which commonly involve the lungs with primarily radiologic manifestations of atypical or organizing pneumonia. It can cause multisystemic involvement including central nervous system symptoms. One of these neurologic manifestations is posterior reversible encephalopathy syndrome (PRES). It is suggested that the increased levels of cytokines and inflammatory mediators in the course of the disease are responsible for cerebrovascular endothelial dysfunction and disruption of the blood-brain barrier. To the best of our knowledge, no pediatric PRES has been reported related to coronavirus disease 2019. Here, we present a pediatric PRES case associated with severe acute respiratory syndrome coronavirus 2 infection.